Characterization of human tibrovirus envelope glycoproteins
Human tibroviruses are poorly characterized emerging rhabdoviruses associated with either asymptomatic infection or severe disease with a case fatality rate as high as 60% in humans. However, the extent and burden of human infection as well as factors behind differences in infection outcomes are lar...
Saved in:
Published in | Journal of Virology Vol. 98; no. 7; p. e0049924 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
23.07.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Human tibroviruses are poorly characterized emerging rhabdoviruses associated with either asymptomatic infection or severe disease with a case fatality rate as high as 60% in humans. However, the extent and burden of human infection as well as factors behind differences in infection outcomes are largely unknown. In this study, we characterized human tibrovirus glycoproteins, which play a key role in virus-host interactions, mainly focusing on their structural and antigenic differences and cellular tropism. Our results provide critical information for understanding the biological properties of these novel viruses and for developing appropriate preparedness interventions such as diagnostic tools, vaccines, and effective therapies. |
---|---|
AbstractList | Human tibroviruses are poorly characterized emerging rhabdoviruses associated with either asymptomatic infection or severe disease with a case fatality rate as high as 60% in humans. However, the extent and burden of human infection as well as factors behind differences in infection outcomes are largely unknown. In this study, we characterized human tibrovirus glycoproteins, which play a key role in virus-host interactions, mainly focusing on their structural and antigenic differences and cellular tropism. Our results provide critical information for understanding the biological properties of these novel viruses and for developing appropriate preparedness interventions such as diagnostic tools, vaccines, and effective therapies. Tibroviruses are novel rhabdoviruses detected in humans, cattle, and arthropods. Four tibroviruses are known to infect humans: Bas-Congo virus (BASV), Ekpoma virus 1 (EKV-1), Ekpoma virus 2, and Mundri virus. However, since none of them has been isolated, their biological properties are largely unknown. We aimed to characterize the human tibrovirus glycoprotein (G), which likely plays a pivotal role in viral tropism and pathogenicity. Human tibrovirus Gs were found to share some primary structures and display 14 conserved cysteine residues, although their overall amino acid homology was low (29%–48%). Multiple potential glycosylation sites were found on the G molecules, and endoglycosidase H- and peptide-N-glycosidase F-sensitive glycosylation was confirmed. AlphaFold-predicted three-dimensional (3D) structures of human tibrovirus Gs were overall similar. Membrane fusion mediated by these tibrovirus Gs was induced by acidic pH. The low pH-induced conformational change that triggers fusion was reversible. Virus-like particles (VLPs) were produced by transient expression of Gs in cultured cells and used to produce mouse antisera. Using vesicular stomatitis Indiana virus pseudotyped with Gs, we found that the antisera to the respective tibrovirus VLPs showed limited cross-neutralizing activity. It was also found that human C-type lectins and T-cell immunoglobulin mucin 1 acted as attachment factors for G-mediated entry into cells. Interestingly, BASV-G showed the highest ability to utilize these molecules. The viruses infected a wide range of cell lines with preferential tropism for human-derived cells whereas the preference of EKV-1 was unique compared with the other human tibroviruses. These findings provide fundamental information to understand the biological properties of the human tibroviruses. Tibroviruses are novel rhabdoviruses detected in humans, cattle, and arthropods. Four tibroviruses are known to infect humans: Bas-Congo virus (BASV), Ekpoma virus 1 (EKV-1), Ekpoma virus 2, and Mundri virus. However, since none of them has been isolated, their biological properties are largely unknown. We aimed to characterize the human tibrovirus glycoprotein (G), which likely plays a pivotal role in viral tropism and pathogenicity. Human tibrovirus Gs were found to share some primary structures and display 14 conserved cysteine residues, although their overall amino acid homology was low (29%–48%). Multiple potential glycosylation sites were found on the G molecules, and endoglycosidase H- and peptide-N-glycosidase F-sensitive glycosylation was confirmed. AlphaFold-predicted three-dimensional (3D) structures of human tibrovirus Gs were overall similar. Membrane fusion mediated by these tibrovirus Gs was induced by acidic pH. The low pH-induced conformational change that triggers fusion was reversible. Virus-like particles (VLPs) were produced by transient expression of Gs in cultured cells and used to produce mouse antisera. Using vesicular stomatitis Indiana virus pseudotyped with Gs, we found that the antisera to the respective tibrovirus VLPs showed limited cross-neutralizing activity. It was also found that human C-type lectins and T-cell immunoglobulin mucin 1 acted as attachment factors for G-mediated entry into cells. Interestingly, BASV-G showed the highest ability to utilize these molecules. The viruses infected a wide range of cell lines with preferential tropism for human-derived cells whereas the preference of EKV-1 was unique compared with the other human tibroviruses. These findings provide fundamental information to understand the biological properties of the human tibroviruses.IMPORTANCEHuman tibroviruses are poorly characterized emerging rhabdoviruses associated with either asymptomatic infection or severe disease with a case fatality rate as high as 60% in humans. However, the extent and burden of human infection as well as factors behind differences in infection outcomes are largely unknown. In this study, we characterized human tibrovirus glycoproteins, which play a key role in virus-host interactions, mainly focusing on their structural and antigenic differences and cellular tropism. Our results provide critical information for understanding the biological properties of these novel viruses and for developing appropriate preparedness interventions such as diagnostic tools, vaccines, and effective therapies. Tibroviruses are novel rhabdoviruses detected in humans, cattle, and arthropods. Four tibroviruses are known to infect humans: Bas-Congo virus (BASV), Ekpoma virus 1 (EKV-1), Ekpoma virus 2, and Mundri virus. However, since none of them has been isolated, their biological properties are largely unknown. We aimed to characterize the human tibrovirus glycoprotein (G), which likely plays a pivotal role in viral tropism and pathogenicity. Human tibrovirus Gs were found to share some primary structures and display 14 conserved cysteine residues, although their overall amino acid homology was low (29%-48%). Multiple potential glycosylation sites were found on the G molecules, and endoglycosidase H- and peptide-N-glycosidase F-sensitive glycosylation was confirmed. AlphaFold-predicted three-dimensional (3D) structures of human tibrovirus Gs were overall similar. Membrane fusion mediated by these tibrovirus Gs was induced by acidic pH. The low pH-induced conformational change that triggers fusion was reversible. Virus-like particles (VLPs) were produced by transient expression of Gs in cultured cells and used to produce mouse antisera. Using vesicular stomatitis Indiana virus pseudotyped with Gs, we found that the antisera to the respective tibrovirus VLPs showed limited cross-neutralizing activity. It was also found that human C-type lectins and T-cell immunoglobulin mucin 1 acted as attachment factors for G-mediated entry into cells. Interestingly, BASV-G showed the highest ability to utilize these molecules. The viruses infected a wide range of cell lines with preferential tropism for human-derived cells whereas the preference of EKV-1 was unique compared with the other human tibroviruses. These findings provide fundamental information to understand the biological properties of the human tibroviruses.Tibroviruses are novel rhabdoviruses detected in humans, cattle, and arthropods. Four tibroviruses are known to infect humans: Bas-Congo virus (BASV), Ekpoma virus 1 (EKV-1), Ekpoma virus 2, and Mundri virus. However, since none of them has been isolated, their biological properties are largely unknown. We aimed to characterize the human tibrovirus glycoprotein (G), which likely plays a pivotal role in viral tropism and pathogenicity. Human tibrovirus Gs were found to share some primary structures and display 14 conserved cysteine residues, although their overall amino acid homology was low (29%-48%). Multiple potential glycosylation sites were found on the G molecules, and endoglycosidase H- and peptide-N-glycosidase F-sensitive glycosylation was confirmed. AlphaFold-predicted three-dimensional (3D) structures of human tibrovirus Gs were overall similar. Membrane fusion mediated by these tibrovirus Gs was induced by acidic pH. The low pH-induced conformational change that triggers fusion was reversible. Virus-like particles (VLPs) were produced by transient expression of Gs in cultured cells and used to produce mouse antisera. Using vesicular stomatitis Indiana virus pseudotyped with Gs, we found that the antisera to the respective tibrovirus VLPs showed limited cross-neutralizing activity. It was also found that human C-type lectins and T-cell immunoglobulin mucin 1 acted as attachment factors for G-mediated entry into cells. Interestingly, BASV-G showed the highest ability to utilize these molecules. The viruses infected a wide range of cell lines with preferential tropism for human-derived cells whereas the preference of EKV-1 was unique compared with the other human tibroviruses. These findings provide fundamental information to understand the biological properties of the human tibroviruses.Human tibroviruses are poorly characterized emerging rhabdoviruses associated with either asymptomatic infection or severe disease with a case fatality rate as high as 60% in humans. However, the extent and burden of human infection as well as factors behind differences in infection outcomes are largely unknown. In this study, we characterized human tibrovirus glycoproteins, which play a key role in virus-host interactions, mainly focusing on their structural and antigenic differences and cellular tropism. Our results provide critical information for understanding the biological properties of these novel viruses and for developing appropriate preparedness interventions such as diagnostic tools, vaccines, and effective therapies.IMPORTANCEHuman tibroviruses are poorly characterized emerging rhabdoviruses associated with either asymptomatic infection or severe disease with a case fatality rate as high as 60% in humans. However, the extent and burden of human infection as well as factors behind differences in infection outcomes are largely unknown. In this study, we characterized human tibrovirus glycoproteins, which play a key role in virus-host interactions, mainly focusing on their structural and antigenic differences and cellular tropism. Our results provide critical information for understanding the biological properties of these novel viruses and for developing appropriate preparedness interventions such as diagnostic tools, vaccines, and effective therapies. Tibroviruses are novel rhabdoviruses detected in humans, cattle, and arthropods. Four tibroviruses are known to infect humans: Bas-Congo virus (BASV), Ekpoma virus 1 (EKV-1), Ekpoma virus 2, and Mundri virus. However, since none of them has been isolated, their biological properties are largely unknown. We aimed to characterize the human tibrovirus glycoprotein (G), which likely plays a pivotal role in viral tropism and pathogenicity. Human tibrovirus Gs were found to share some primary structures and display 14 conserved cysteine residues, although their overall amino acid homology was low (29%-48%). Multiple potential glycosylation sites were found on the G molecules, and endoglycosidase H- and peptide-N-glycosidase F-sensitive glycosylation was confirmed. AlphaFold-predicted three-dimensional (3D) structures of human tibrovirus Gs were overall similar. Membrane fusion mediated by these tibrovirus Gs was induced by acidic pH. The low pH-induced conformational change that triggers fusion was reversible. Virus-like particles (VLPs) were produced by transient expression of Gs in cultured cells and used to produce mouse antisera. Using vesicular stomatitis Indiana virus pseudotyped with Gs, we found that the antisera to the respective tibrovirus VLPs showed limited cross-neutralizing activity. It was also found that human C-type lectins and T-cell immunoglobulin mucin 1 acted as attachment factors for G-mediated entry into cells. Interestingly, BASV-G showed the highest ability to utilize these molecules. The viruses infected a wide range of cell lines with preferential tropism for human-derived cells whereas the preference of EKV-1 was unique compared with the other human tibroviruses. These findings provide fundamental information to understand the biological properties of the human tibroviruses. Human tibroviruses are poorly characterized emerging rhabdoviruses associated with either asymptomatic infection or severe disease with a case fatality rate as high as 60% in humans. However, the extent and burden of human infection as well as factors behind differences in infection outcomes are largely unknown. In this study, we characterized human tibrovirus glycoproteins, which play a key role in virus-host interactions, mainly focusing on their structural and antigenic differences and cellular tropism. Our results provide critical information for understanding the biological properties of these novel viruses and for developing appropriate preparedness interventions such as diagnostic tools, vaccines, and effective therapies. |
Author | Eun-sil Park Boniface Pongombo Lombe Masahiro Kajihara Hiroko Miyamoto Manabu Igarashi Yannick Munyeku-Bazitama Akina Mori-Kajihara Jean-Jacques Muyembe-Tamfum Ayato Takada Sheila Makiala-Mandanda Takanari Hattori Takeshi Saito Shigeru Morikawa |
Author_xml | – sequence: 1 givenname: Yannick orcidid: 0000-0001-8303-318X surname: Munyeku-Bazitama fullname: Munyeku-Bazitama, Yannick organization: Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo, Département de Biologie Médicale, Faculté de Médecine, Université de Kinshasa, Kinshasa, Democratic Republic of Congo – sequence: 2 givenname: Takeshi surname: Saito fullname: Saito, Takeshi organization: Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan – sequence: 3 givenname: Takanari surname: Hattori fullname: Hattori, Takanari organization: Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan – sequence: 4 givenname: Hiroko surname: Miyamoto fullname: Miyamoto, Hiroko organization: Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan – sequence: 5 givenname: Boniface Pongombo surname: Lombe fullname: Lombe, Boniface Pongombo organization: Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan, Faculté de Médecine Vétérinaire, Université Pédagogique National, Kinshasa, Democratic Republic of Congo, Central Veterinary Laboratory of Kinshasa, Kinshasa, Democratic Republic of Congo – sequence: 6 givenname: Akina surname: Mori-Kajihara fullname: Mori-Kajihara, Akina organization: Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan – sequence: 7 givenname: Masahiro surname: Kajihara fullname: Kajihara, Masahiro organization: Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan – sequence: 8 givenname: Jean-Jacques surname: Muyembe-Tamfum fullname: Muyembe-Tamfum, Jean-Jacques organization: Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo, Département de Biologie Médicale, Faculté de Médecine, Université de Kinshasa, Kinshasa, Democratic Republic of Congo – sequence: 9 givenname: Manabu surname: Igarashi fullname: Igarashi, Manabu organization: Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan, International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan – sequence: 10 givenname: Eun-sil surname: Park fullname: Park, Eun-sil organization: Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 11 givenname: Shigeru surname: Morikawa fullname: Morikawa, Shigeru organization: Department of Microbiology, Faculty of Veterinary Medicine, Okayama University of Science, Ehime, Japan – sequence: 12 givenname: Sheila surname: Makiala-Mandanda fullname: Makiala-Mandanda, Sheila organization: Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo, Département de Biologie Médicale, Faculté de Médecine, Université de Kinshasa, Kinshasa, Democratic Republic of Congo – sequence: 13 givenname: Ayato orcidid: 0000-0003-2464-6642 surname: Takada fullname: Takada, Ayato organization: Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan, International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan, One Health Research Center, Hokkaido University, Sapporo, Japan, Department of Disease Control, School of Veterinary Medicine, University of Zambia, Lusaka, Zambia |
BackLink | https://cir.nii.ac.jp/crid/1871429166522079488$$DView record in CiNii https://www.ncbi.nlm.nih.gov/pubmed/38953631$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kM1LXDEUxUOx1HHqzrW8hQsLfTbfyaWLIoNtBcFNC92FvEzGibyXjMl7A_avb3Ss6EK43Lu4Pw7nnAO0F1P0CB0RfEYI1V9ut-EMYw7QUv4OzQgG3QpB-B6aYUxpK5j-s48OSwkdJkooAMw_oH2mQTDJyAx9Xaxttm70Ofy1Y0ixSatmPQ02NmPoctqGPJXGx63v08Y3N_29S5ucRh9i-Yjer2xf_OHTnaPf3y9-LX62V9c_LhfnV63liowtJ5yBBOWUZFrDCrhQnYKO4CVWAljXSY2508AsdEvnnCT1Mka91RRLz-bo2053M3WDXzofx2x7s8lhsPneJBvM608Ma3OTtqZWJAWvQefo9Ekhp7vJl9EMoTjf9zb6NBXDqhFWh0BFP-1QWwZqbtOUY81mCH5Q06YWbh4LN5RX9vilsWdH_-utwOcd4HIqJfvVM_KG3skOjyEYFx420YpwCkRKQSlWwLVm_wAM7ZaZ |
Cites_doi | 10.1128/jvi.78.6.2943-2947.2004 10.1016/j.celrep.2020.108042 10.1016/j.bpj.2016.04.035 10.1006/viro.2002.1730 10.1021/acsomega.2c03517 10.1371/journal.ppat.1002924 10.1371/journal.pntd.0003631 10.1128/JVI.01183-13 10.1128/JVI.78.21.12090-12095.2004 10.3389/fmicb.2019.00856 10.4049/jimmunol.178.9.5839 10.1016/j.chom.2019.12.012 10.1074/jbc.M202104200 10.1038/s41586-021-03819-2 10.1128/mbio.03060-21 10.1016/0378-1135(80)90029-2 10.1371/journal.ppat.1008383 10.1093/infdis/jir334 10.1128/genomeA.00089-15 10.1128/CVI.00170-10 10.1093/glycob/cwy053 10.1038/s41592-022-01488-1 10.1128/JVI.02021-09 10.1371/journal.ppat.1003232 10.1371/journal.ppat.1009910 10.1038/s41467-018-03432-4 10.1071/bi9860225 10.1126/science.aap9072 10.3390/biology12060878 10.1128/jvi.76.10.4855-4865.2002 10.1038/nrmicro3469 10.3390/v14102124 10.1080/14712598.2020.1787981 10.1128/JVI.02265-13 10.1073/pnas.94.26.14764 10.1016/0378-1135(89)90079-5 10.1128/jvi.77.2.1069-1074.2003 10.1084/jem.20021840 10.1126/science.1135710 10.1101/2021.10.04.463034 10.1074/jbc.M708955200 10.3390/v14020210 10.1007/s00018-008-7534-3 10.3390/v12030252 10.1016/bs.aivir.2019.05.003 10.1016/j.vaccine.2014.02.031 10.1099/0022-1317-80-5-1211 10.1016/j.virol.2014.09.009 10.1016/j.virol.2015.11.002 |
ContentType | Journal Article |
Copyright | Copyright © 2024 American Society for Microbiology. Copyright © 2024 American Society for Microbiology. 2024 American Society for Microbiology. |
Copyright_xml | – notice: Copyright © 2024 American Society for Microbiology. – notice: Copyright © 2024 American Society for Microbiology. 2024 American Society for Microbiology. |
DBID | RYH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1128/jvi.00499-24 |
DatabaseName | CiNii Complete CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1098-5514 |
Editor | Heise, Mark T. |
Editor_xml | – sequence: 1 givenname: Mark T. surname: Heise fullname: Heise, Mark T. |
ExternalDocumentID | PMC11265436 00499-24 38953631 10_1128_jvi_00499_24 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Japan Agency for Medical Research and Development (AMED) grantid: JP23fk0108624 – fundername: Japan Agency for Medical Research and Development (AMED) grantid: JP23wm0125008 – fundername: Japan Agency for Medical Research and Development (AMED) grantid: JP23jm0110019 – fundername: Japan Agency for Medical Research and Development (AMED) grantid: JP23wm0125008 funderid: https://doi.org/10.13039/100009619 – fundername: Japan Agency for Medical Research and Development (AMED) grantid: JP23jm0110019 funderid: https://doi.org/10.13039/100009619 – fundername: Japan Agency for Medical Research and Development (AMED) grantid: JP23fk0108624 funderid: https://doi.org/10.13039/100009619 – fundername: ; grantid: JP23wm0125008 – fundername: ; grantid: JP23fk0108624 – fundername: ; grantid: JP23jm0110019 |
GroupedDBID | --- -~X 0R~ 18M 29L 2WC 39C 4.4 53G 5GY 5RE 5VS 85S AAFWJ AAGFI ABPPZ ACGFO ACNCT ADBBV AENEX AGVNZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW CS3 DIK E3Z EBS F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 N9A O9- OK1 P2P RHI RNS RPM RSF RYH TR2 UPT W2D W8F WH7 WOQ YQT ~02 ~KM AAYXX CITATION CGR CUY CVF ECM EIF NPM RHF UCJ 7X8 5PM |
ID | FETCH-LOGICAL-a471t-41439697c763889f9457b79b10d07593bb6804c893a9bdccc619bd332ea8206e3 |
ISSN | 0022-538X 1098-5514 |
IngestDate | Thu Aug 21 18:35:23 EDT 2025 Fri Jul 11 02:54:52 EDT 2025 Wed Jul 24 04:33:25 EDT 2024 Wed Feb 19 02:00:20 EST 2025 Tue Jul 01 01:32:45 EDT 2025 Thu Jun 26 23:00:48 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Ekpoma virus 2 Ekpoma virus 1 glycoprotein Mundri virus Bas-Congo virus Tibrogargan virus tibrovirus |
Language | English |
License | All Rights Reserved. https://doi.org/10.1128/ASMCopyrightv2 All Rights Reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-a471t-41439697c763889f9457b79b10d07593bb6804c893a9bdccc619bd332ea8206e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Present address: Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA The authors declare no conflict of interest. |
ORCID | 0000-0001-8303-318X 0000-0003-2464-6642 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/11265436 |
PMID | 38953631 |
PQID | 3075375319 |
PQPubID | 23479 |
PageCount | 23 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11265436 proquest_miscellaneous_3075375319 asm2_journals_10_1128_jvi_00499_24 pubmed_primary_38953631 crossref_primary_10_1128_jvi_00499_24 nii_cinii_1871429166522079488 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-07-23 |
PublicationDateYYYYMMDD | 2024-07-23 |
PublicationDate_xml | – month: 07 year: 2024 text: 2024-07-23 day: 23 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
PublicationTitle | Journal of Virology |
PublicationTitleAbbrev | J Virol |
PublicationTitleAlternate | J Virol |
PublicationYear | 2024 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | e_1_3_3_50_2 e_1_3_3_16_2 e_1_3_3_18_2 e_1_3_3_39_2 e_1_3_3_12_2 e_1_3_3_37_2 e_1_3_3_14_2 e_1_3_3_35_2 e_1_3_3_33_2 e_1_3_3_10_2 e_1_3_3_31_2 e_1_3_3_40_2 e_1_3_3_5_2 e_1_3_3_7_2 e_1_3_3_9_2 e_1_3_3_27_2 e_1_3_3_29_2 e_1_3_3_23_2 e_1_3_3_48_2 e_1_3_3_25_2 e_1_3_3_46_2 e_1_3_3_44_2 e_1_3_3_3_2 e_1_3_3_21_2 e_1_3_3_42_2 e_1_3_3_51_2 e_1_3_3_17_2 e_1_3_3_19_2 e_1_3_3_38_2 e_1_3_3_13_2 e_1_3_3_36_2 e_1_3_3_15_2 e_1_3_3_34_2 e_1_3_3_32_2 e_1_3_3_11_2 e_1_3_3_30_2 e_1_3_3_6_2 e_1_3_3_8_2 e_1_3_3_28_2 e_1_3_3_49_2 e_1_3_3_24_2 e_1_3_3_47_2 e_1_3_3_26_2 e_1_3_3_45_2 e_1_3_3_2_2 e_1_3_3_20_2 e_1_3_3_43_2 e_1_3_3_4_2 e_1_3_3_22_2 e_1_3_3_41_2 Roche, S, Albertini, AAV, Lepault, J, Bressanelli, S, Gaudin, Y (B14) 2008; 65 Nakayama, E, Tomabechi, D, Matsuno, K, Kishida, N, Yoshida, R, Feldmann, H, Takada, A (B46) 2011; 204 Suppl 3 Maruyama, J, Miyamoto, H, Kajihara, M, Ogawa, H, Maeda, K, Sakoda, Y, Yoshida, R, Takada, A (B32) 2014; 88 Belot, L, Ouldali, M, Roche, S, Legrand, P, Gaudin, Y, Albertini, AA (B13) 2020; 16 Beilstein, F, Abou Hamdan, A, Raux, H, Belot, L, Ouldali, M, Albertini, AA, Gaudin, Y (B22) 2020; 32 Jemielity, S, Wang, JJ, Chan, YK, Ahmed, AA, Li, W, Monahan, S, Bu, X, Farzan, M, Freeman, GJ, Umetsu, DT, Dekruyff, RH, Choe, H (B34) 2013; 9 Yang, F, Lin, S, Ye, F, Yang, J, Qi, J, Chen, Z, Lin, X, Wang, J, Yue, D, Cheng, Y, Chen, Z, Chen, H, You, Y, Zhang, Z, Yang, Y, Yang, M, Sun, H, Li, Y, Cao, Y, Yang, S, Wei, Y, Gao, GF, Lu, G (B12) 2020; 27 Rehman, S, Bishnoi, S, Roy, R, Kumari, A, Jayakumar, H, Gupta, S, Kar, P, Pattnaik, AK, Nayak, D (B24) 2022; 7 Matsuno, K, Kishida, N, Usami, K, Igarashi, M, Yoshida, R, Nakayama, E, Shimojima, M, Feldmann, H, Irimura, T, Kawaoka, Y, Takada, A (B31) 2010; 84 Munis, AM, Bentley, EM, Takeuchi, Y (B17) 2020; 20 Cybinski, DH, St. George, TD, Standfast, HA, McGregor, A (B6) 1980; 5 Marzi, A, Gramberg, T, Simmons, G, Möller, P, Rennekamp, AJ, Krumbiegel, M, Geier, M, Eisemann, J, Turza, N, Saunier, B, Steinkasserer, A, Becker, S, Bates, P, Hofmann, H, Pöhlmann, S (B30) 2004; 78 Moller-Tank, S, Maury, W (B35) 2014; 468–470 Nakayama, E, Yokoyama, A, Miyamoto, H, Igarashi, M, Kishida, N, Matsuno, K, Marzi, A, Feldmann, H, Ito, K, Saijo, M, Takada, A (B43) 2010; 17 Di Lella, S, Herrmann, A, Mair, CM (B26) 2016; 110 Nikolic, J, Belot, L, Raux, H, Legrand, P, Gaudin, Y, A Albertini, A (B16) 2018; 9 Takada, A, Fujioka, K, Tsuiji, M, Morikawa, A, Higashi, N, Ebihara, H, Kobasa, D, Feldmann, H, Irimura, T, Kawaoka, Y (B29) 2004; 78 Amara, A, Mercer, J (B36) 2015; 13 Noda, T, Sagara, H, Suzuki, E, Takada, A, Kida, H, Kawaoka, Y (B45) 2002; 76 Roche, S, Rey, FA, Gaudin, Y, Bressanelli, S (B15) 2007; 315 Saito, T, Hattori, T, Okuya, K, Manzoor, R, Miyamoto, H, Kajihara, M, Takada, A (B41) 2022; 13 Gibbs, EPJ, Calisher, CH, Tesh, RB, Lazuick, JS, Bowen, R, Greiner, EC (B8) 1989; 19 Jumper, J, Evans, R, Pritzel, A, Green, T, Figurnov, M, Ronneberger, O, Tunyasuvunakool, K, Bates, R, Žídek, A, Potapenko, A (B50) 2021; 596 Cybinski, DH, Gard, GP (B7) 1986; 39 B4 Fontana, D, Kratje, R, Etcheverrigaray, M, Prieto, C (B25) 2014; 32 Mirdita, M, Schütze, K, Moriwaki, Y, Heo, L, Ovchinnikov, S, Steinegger, M (B49) 2022; 19 Steffen, I, Liss, NM, Schneider, BS, Fair, JN, Chiu, CY, Simmons, G (B19) 2013; 87 Maruyama, J, Nao, N, Miyamoto, H, Maeda, K, Ogawa, H, Yoshida, R, Igarashi, M, Takada, A (B40) 2016; 488 Edridge, AWD, Abd-Elfarag, G, Deijs, M, Jebbink, MF, Boele van Hensbroek, M, van der Hoek, L (B3) 2022; 14 Yang, G, Ojha, CR, Russell, CJ (B27) 2021; 17 B48 Simmons, G, Reeves, JD, Grogan, CC, Vandenberghe, LH, Baribaud, F, Whitbeck, JC, Burke, E, Buchmeier, MJ, Soilleux, EJ, Riley, JL, Doms, RW, Bates, P, Pöhlmann, S (B33) 2003; 305 Lauck, M, Yú, SQ, Caì, Y, Hensley, LE, Chiu, CY, O’Connor, DH, Kuhn, JH (B9) 2015; 3 Ortega, V, Stone, JA, Contreras, EM, Iorio, RM, Aguilar, HC (B21) 2019; 29 Higashi, N, Fujioka, K, Denda-Nagai, K, Hashimoto, S-I, Nagai, S, Sato, T, Fujita, Y, Morikawa, A, Tsuiji, M, Miyata-Takeuchi, M, Sano, Y, Suzuki, N, Yamamoto, K, Matsushima, K, Irimura, T (B38) 2002; 277 Takada, A, Robison, C, Goto, H, Sanchez, A, Murti, KG, Whitt, MA, Kawaoka, Y (B47) 1997; 94 Shepherd, JG, Davis, C, Streicker, DG, Thomson, EC (B11) 2023; 12 Bach, P, Kamphuis, E, Odermatt, B, Sutter, G, Buchholz, CJ, Kalinke, U (B23) 2007; 178 Grard, G, Fair, JN, Lee, D, Slikas, E, Steffen, I, Muyembe, J-J, Sittler, T, Veeraraghavan, N, Ruby, JG, Wang, C, Makuwa, M, Mulembakani, P, Tesh, RB, Mazet, J, Rimoin, AW, Taylor, T, Schneider, BS, Simmons, G, Delwart, E, Wolfe, ND, Chiu, CY, Leroy, EM (B1) 2012; 8 Walker, PJ, Kongsuwan, K (B18) 1999; 80 Hattori, T, Saito, T, Miyamoto, H, Kajihara, M, Igarashi, M, Takada, A (B42) 2022; 14 Sun, X, Belouzard, S, Whittaker, GR (B20) 2008; 283 Stremlau, MH, Andersen, KG, Folarin, OA, Grove, JN, Odia, I, Ehiane, PE, Omoniwa, O, Omoregie, O, Jiang, P-P, Yozwiak, NL (B2) 2015; 9 Tassaneetrithep, B, Burgess, TH, Granelli-Piperno, A, Trumpfheller, C, Finke, J, Sun, W, Eller, MA, Pattanapanyasat, K, Sarasombath, S, Birx, DL, Steinman, RM, Schlesinger, S, Marovich, MA (B28) 2003; 197 Takada, A, Feldmann, H, Stroeher, U, Bray, M, Watanabe, S, Ito, H, McGregor, M, Kawaoka, Y (B44) 2003; 77 Caì, Y, Yú, S, Jangra, RK, Postnikova, EN, Wada, J, Tesh, RB, Whelan, SPJ, Lauck, M, Wiley, MR, Finch, CL, Radoshitzky, SR, O’Connor, DH, Palacios, G, Chandran, K, Chiu, CY, Kuhn, JH (B37) 2019; 10 Babayan, SA, Orton, RJ, Streicker, DG (B39) 2018; 362 Belot, L, Albertini, A, Gaudin, Y (B10) 2019; 104 Kuhn, JH, Pān, H, Chiu, CY, Stremlau, M (B5) 2020; 12 |
References_xml | – ident: e_1_3_3_30_2 doi: 10.1128/jvi.78.6.2943-2947.2004 – ident: e_1_3_3_23_2 doi: 10.1016/j.celrep.2020.108042 – ident: e_1_3_3_27_2 doi: 10.1016/j.bpj.2016.04.035 – ident: e_1_3_3_34_2 doi: 10.1006/viro.2002.1730 – ident: e_1_3_3_25_2 doi: 10.1021/acsomega.2c03517 – ident: e_1_3_3_2_2 doi: 10.1371/journal.ppat.1002924 – ident: e_1_3_3_3_2 doi: 10.1371/journal.pntd.0003631 – ident: e_1_3_3_20_2 doi: 10.1128/JVI.01183-13 – ident: e_1_3_3_31_2 doi: 10.1128/JVI.78.21.12090-12095.2004 – ident: e_1_3_3_38_2 doi: 10.3389/fmicb.2019.00856 – ident: e_1_3_3_24_2 doi: 10.4049/jimmunol.178.9.5839 – ident: e_1_3_3_13_2 doi: 10.1016/j.chom.2019.12.012 – ident: e_1_3_3_39_2 doi: 10.1074/jbc.M202104200 – ident: e_1_3_3_51_2 doi: 10.1038/s41586-021-03819-2 – ident: e_1_3_3_42_2 doi: 10.1128/mbio.03060-21 – ident: e_1_3_3_7_2 doi: 10.1016/0378-1135(80)90029-2 – ident: e_1_3_3_14_2 doi: 10.1371/journal.ppat.1008383 – ident: e_1_3_3_47_2 doi: 10.1093/infdis/jir334 – ident: e_1_3_3_10_2 doi: 10.1128/genomeA.00089-15 – ident: e_1_3_3_44_2 doi: 10.1128/CVI.00170-10 – ident: e_1_3_3_22_2 doi: 10.1093/glycob/cwy053 – ident: e_1_3_3_50_2 doi: 10.1038/s41592-022-01488-1 – ident: e_1_3_3_32_2 doi: 10.1128/JVI.02021-09 – ident: e_1_3_3_35_2 doi: 10.1371/journal.ppat.1003232 – ident: e_1_3_3_28_2 doi: 10.1371/journal.ppat.1009910 – ident: e_1_3_3_17_2 doi: 10.1038/s41467-018-03432-4 – ident: e_1_3_3_8_2 doi: 10.1071/bi9860225 – ident: e_1_3_3_40_2 doi: 10.1126/science.aap9072 – ident: e_1_3_3_12_2 doi: 10.3390/biology12060878 – ident: e_1_3_3_46_2 doi: 10.1128/jvi.76.10.4855-4865.2002 – ident: e_1_3_3_37_2 doi: 10.1038/nrmicro3469 – ident: e_1_3_3_43_2 doi: 10.3390/v14102124 – ident: e_1_3_3_18_2 doi: 10.1080/14712598.2020.1787981 – ident: e_1_3_3_33_2 doi: 10.1128/JVI.02265-13 – ident: e_1_3_3_48_2 doi: 10.1073/pnas.94.26.14764 – ident: e_1_3_3_9_2 doi: 10.1016/0378-1135(89)90079-5 – ident: e_1_3_3_45_2 doi: 10.1128/jvi.77.2.1069-1074.2003 – ident: e_1_3_3_5_2 – ident: e_1_3_3_29_2 doi: 10.1084/jem.20021840 – ident: e_1_3_3_16_2 doi: 10.1126/science.1135710 – ident: e_1_3_3_49_2 doi: 10.1101/2021.10.04.463034 – ident: e_1_3_3_21_2 doi: 10.1074/jbc.M708955200 – ident: e_1_3_3_4_2 doi: 10.3390/v14020210 – ident: e_1_3_3_15_2 doi: 10.1007/s00018-008-7534-3 – ident: e_1_3_3_6_2 doi: 10.3390/v12030252 – ident: e_1_3_3_11_2 doi: 10.1016/bs.aivir.2019.05.003 – ident: e_1_3_3_26_2 doi: 10.1016/j.vaccine.2014.02.031 – ident: e_1_3_3_19_2 doi: 10.1099/0022-1317-80-5-1211 – ident: e_1_3_3_36_2 doi: 10.1016/j.virol.2014.09.009 – ident: e_1_3_3_41_2 doi: 10.1016/j.virol.2015.11.002 – volume: 12 year: 2023 ident: B11 article-title: Emerging rhabdoviruses and human infection publication-title: Biology (Basel) doi: 10.3390/biology12060878 – volume: 315 start-page: 843 year: 2007 end-page: 848 ident: B15 article-title: Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G publication-title: Science doi: 10.1126/science.1135710 – volume: 9 year: 2018 ident: B16 article-title: Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein publication-title: Nat Commun doi: 10.1038/s41467-018-03432-4 – volume: 104 start-page: 147 year: 2019 end-page: 183 ident: B10 article-title: Structural and cellular biology of rhabdovirus entry publication-title: Adv Virus Res doi: 10.1016/bs.aivir.2019.05.003 – volume: 80 start-page: 1211 year: 1999 end-page: 1220 ident: B18 article-title: Deduced structural model for animal rhabdovirus glycoproteins publication-title: J Gen Virol doi: 10.1099/0022-1317-80-5-1211 – volume: 283 start-page: 6418 year: 2008 end-page: 6427 ident: B20 article-title: Molecular architecture of the bipartite fusion loops of vesicular stomatitis virus glycoprotein G, a class III viral fusion protein publication-title: J Biol Chem doi: 10.1074/jbc.M708955200 – volume: 362 start-page: 577 year: 2018 end-page: 580 ident: B39 article-title: Predicting reservoir hosts and arthropod vectors from evolutionary signatures in RNA virus genomes publication-title: Science doi: 10.1126/science.aap9072 – volume: 204 Suppl 3 start-page: S978 year: 2011 end-page: 85 ident: B46 article-title: Antibody-dependent enhancement of Marburg virus infection publication-title: J Infect Dis doi: 10.1093/infdis/jir334 – volume: 488 start-page: 43 year: 2016 end-page: 50 ident: B40 article-title: Characterization of the glycoproteins of bat-derived influenza viruses publication-title: Virology doi: 10.1016/j.virol.2015.11.002 – volume: 13 year: 2022 ident: B41 article-title: Molecular mechanisms underlying the cellular entry and host range restriction of Lujo virus publication-title: mBio doi: 10.1128/mbio.03060-21 – volume: 88 start-page: 99 year: 2014 end-page: 109 ident: B32 article-title: Characterization of the envelope glycoprotein of a novel filovirus, lloviu virus publication-title: J Virol doi: 10.1128/JVI.02265-13 – volume: 10 start-page: 856 year: 2019 ident: B37 article-title: Human, nonhuman primate, and bat cells are broadly susceptible to Tibrovirus particle cell entry publication-title: Front Microbiol doi: 10.3389/fmicb.2019.00856 – volume: 84 start-page: 5140 year: 2010 end-page: 5147 ident: B31 article-title: Different potential of C-type lectin-mediated entry between Marburg virus strains publication-title: J Virol doi: 10.1128/JVI.02021-09 – volume: 77 start-page: 1069 year: 2003 end-page: 1074 ident: B44 article-title: Identification of protective epitopes on Ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses publication-title: J Virol doi: 10.1128/jvi.77.2.1069-1074.2003 – volume: 78 start-page: 2943 year: 2004 end-page: 2947 ident: B29 article-title: Human macrophage C-type lectin specific for galactose and N -acetylgalactosamine promotes filovirus entry publication-title: J Virol doi: 10.1128/jvi.78.6.2943-2947.2004 – volume: 8 year: 2012 ident: B1 article-title: A novel rhabdovirus associated with acute hemorrhagic fever in Central Africa publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1002924 – volume: 5 start-page: 301 year: 1980 end-page: 308 ident: B6 article-title: Isolation of tibrogargan virus, a new Australian rhabdovirus, from Culicoides brevitarsis publication-title: Vet Microbiol doi: 10.1016/0378-1135(80)90029-2 – volume: 29 start-page: 2 year: 2019 end-page: 21 ident: B21 article-title: Addicted to sugar: roles of glycans in the order Mononegavirales publication-title: Glycobiology doi: 10.1093/glycob/cwy053 – volume: 277 start-page: 20686 year: 2002 end-page: 20693 ident: B38 article-title: The macrophage C-type lectin specific for galactose/N-acetylgalactosamine is an endocytic receptor expressed on monocyte-derived immature dendritic cells publication-title: J Biol Chem doi: 10.1074/jbc.M202104200 – volume: 27 start-page: 441 year: 2020 end-page: 453 ident: B12 article-title: Structural analysis of rabies virus glycoprotein reveals pH-dependent conformational changes and interactions with a neutralizing antibody publication-title: Cell Host Microbe doi: 10.1016/j.chom.2019.12.012 – volume: 76 start-page: 4855 year: 2002 end-page: 4865 ident: B45 article-title: Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP publication-title: J Virol doi: 10.1128/jvi.76.10.4855-4865.2002 – volume: 12 year: 2020 ident: B5 article-title: Human tibroviruses: commensals or lethal pathogens? publication-title: Viruses doi: 10.3390/v12030252 – volume: 305 start-page: 115 year: 2003 end-page: 123 ident: B33 article-title: DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells publication-title: Virology doi: 10.1006/viro.2002.1730 – volume: 32 start-page: 2799 year: 2014 end-page: 2804 ident: B25 article-title: Rabies virus-like particles expressed in HEK293 cells publication-title: Vaccine doi: 10.1016/j.vaccine.2014.02.031 – ident: B4 article-title: Genus: tibrovirus | ICTV . Available from : https://ictv.global/report/chapter/rhabdoviridae/rhabdoviridae/tibrovirus . Retrieved 8 Dec 2023 . – volume: 39 start-page: 225 year: 1986 end-page: 232 ident: B7 article-title: Isolation of a new rhabdovirus in Australia related to Tibrogargan virus publication-title: Aust J Biol Sci doi: 10.1071/bi9860225 – volume: 9 year: 2013 ident: B34 article-title: TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1003232 – volume: 468–470 start-page: 565 year: 2014 end-page: 580 ident: B35 article-title: Phosphatidylserine receptors: enhancers of enveloped virus entry and infection publication-title: Virology doi: 10.1016/j.virol.2014.09.009 – volume: 94 start-page: 14764 year: 1997 end-page: 14769 ident: B47 article-title: A system for functional analysis of Ebola virus glycoprotein publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.94.26.14764 – volume: 87 start-page: 9558 year: 2013 end-page: 9568 ident: B19 article-title: Characterization of the bas-Congo virus glycoprotein and its function in pseudotyped viruses publication-title: J Virol doi: 10.1128/JVI.01183-13 – volume: 32 start-page: 108042 year: 2020 ident: B22 article-title: Identification of a pH-sensitive switch in VSV-G and a crystal structure of the G pre-fusion state highlight the VSV-G structural transition pathway publication-title: Cell Rep doi: 10.1016/j.celrep.2020.108042 – volume: 9 year: 2015 ident: B2 article-title: Discovery of novel rhabdoviruses in the blood of healthy individuals from West Africa publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0003631 – volume: 110 start-page: 2293 year: 2016 end-page: 2301 ident: B26 article-title: Modulation of the pH stability of influenza virus hemagglutinin: a host cell adaptation strategy publication-title: Biophys J doi: 10.1016/j.bpj.2016.04.035 – volume: 14 year: 2022 ident: B42 article-title: Single nucleotide variants of the human TIM-1 IgV domain with reduced ability to promote viral entry into cells publication-title: Viruses doi: 10.3390/v14102124 – volume: 16 year: 2020 ident: B13 article-title: Crystal structure of Mokola virus glycoprotein in its post-fusion conformation publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1008383 – volume: 17 year: 2021 ident: B27 article-title: Relationship between hemagglutinin stability and influenza virus persistence after exposure to low pH or supraphysiological heating publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1009910 – volume: 596 start-page: 583 year: 2021 end-page: 589 ident: B50 article-title: Highly accurate protein structure prediction with AlphaFold publication-title: Nature doi: 10.1038/s41586-021-03819-2 – volume: 65 start-page: 1716 year: 2008 end-page: 1728 ident: B14 article-title: Structures of vesicular stomatitis virus glycoprotein: membrane fusion revisited publication-title: Cell Mol Life Sci doi: 10.1007/s00018-008-7534-3 – volume: 17 start-page: 1723 year: 2010 end-page: 1728 ident: B43 article-title: Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies publication-title: Clin Vaccine Immunol doi: 10.1128/CVI.00170-10 – volume: 3 year: 2015 ident: B9 article-title: Genome sequence of bivens arm virus, a tibrovirus belonging to the species Tibrogargan virus (Mononegavirales: Rhabdoviridae) publication-title: Genome Announc doi: 10.1128/genomeA.00089-15 – volume: 19 start-page: 141 year: 1989 end-page: 150 ident: B8 article-title: Bivens arm virus: a new rhabdovirus isolated from Culicoides insignis in Florida and related to Tibrogargan virus of Australia publication-title: Vet Microbiol doi: 10.1016/0378-1135(89)90079-5 – volume: 178 start-page: 5839 year: 2007 end-page: 5847 ident: B23 article-title: Vesicular Stomatitis virus glycoprotein displaying retrovirus-like particles induce a type I IFN receptor-dependent switch to neutralizing IgG antibodies publication-title: J Immunol doi: 10.4049/jimmunol.178.9.5839 – volume: 7 start-page: 32840 year: 2022 end-page: 32848 ident: B24 article-title: Emerging biomedical applications of the vesicular stomatitis virus glycoprotein publication-title: ACS Omega doi: 10.1021/acsomega.2c03517 – ident: B48 article-title: Evans R , O’Neill M , Pritzel A , Antropova N , Senior A , Green T , Žídek A , Bates R , Blackwell S , Yim J , Ronneberger O , Bodenstein S , Zielinski M , Bridgland A , Potapenko A , Cowie A , Tunyasuvunakool K , Jain R , Clancy E , Kohli P , Jumper J , Hassabis D . 2022 . Protein complex prediction with AlphaFold-multimer . bioRxiv . doi: 10.1101/2021.10.04.463034 – volume: 19 start-page: 679 year: 2022 end-page: 682 ident: B49 article-title: ColabFold: making protein folding accessible to all publication-title: Nat Methods doi: 10.1038/s41592-022-01488-1 – volume: 78 start-page: 12090 year: 2004 end-page: 12095 ident: B30 article-title: DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus publication-title: J Virol doi: 10.1128/JVI.78.21.12090-12095.2004 – volume: 13 start-page: 461 year: 2015 end-page: 469 ident: B36 article-title: Viral apoptotic mimicry publication-title: Nat Rev Microbiol doi: 10.1038/nrmicro3469 – volume: 14 year: 2022 ident: B3 article-title: Divergent rhabdovirus discovered in a patient with new-onset nodding syndrome publication-title: Viruses doi: 10.3390/v14020210 – volume: 197 start-page: 823 year: 2003 end-page: 829 ident: B28 article-title: DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells publication-title: J Exp Med doi: 10.1084/jem.20021840 – volume: 20 start-page: 1187 year: 2020 end-page: 1201 ident: B17 article-title: A tool with many applications: vesicular stomatitis virus in research and medicine publication-title: Expert Opin Biol Ther doi: 10.1080/14712598.2020.1787981 |
SSID | ssib017579904 ssib001492792 ssj0014464 ssib058493363 |
Score | 2.4604552 |
Snippet | Human tibroviruses are poorly characterized emerging rhabdoviruses associated with either asymptomatic infection or severe disease with a case fatality rate as... Tibroviruses are novel rhabdoviruses detected in humans, cattle, and arthropods. Four tibroviruses are known to infect humans: Bas-Congo virus (BASV), Ekpoma... |
SourceID | pubmedcentral proquest asm2 pubmed crossref nii |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | e0049924 |
SubjectTerms | Amino Acid Sequence Animals Antibodies, Viral - immunology Cell Line Glycosylation HEK293 Cells Humans Mice Mucin-1 - metabolism Viral Envelope Proteins - genetics Viral Envelope Proteins - metabolism Viral Tropism Virology Virus Internalization Virus-Cell Interactions |
Title | Characterization of human tibrovirus envelope glycoproteins |
URI | https://cir.nii.ac.jp/crid/1871429166522079488 https://www.ncbi.nlm.nih.gov/pubmed/38953631 https://journals.asm.org/doi/10.1128/jvi.00499-24 https://www.proquest.com/docview/3075375319 https://pubmed.ncbi.nlm.nih.gov/PMC11265436 |
Volume | 98 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZoEaiXijcpFAUEpypLEidOLE5QgRZQubCVyimyHYeaZZOqSSrt_nrGzrsPCbhYUezY0sxk5hvbM4PQa49IUPrCdVJMUifAzHVozEMHMx5JiVOWmTpkR9_I_Dj4chKeDOWOTHRJxWdic21cyf9wFd4BX3WU7D9wtp8UXsAz8Bda4DC0f8Xjwz7b8mZAfmZXvgIvuLhQ53WpQ9n0tSB58PP3WhQmL4Nqt-iuglId9TbeZz-q87Vc1s4HtlEVWxmk-UOXORJ9hM93pkwppoMFW8ryVA06rdIJSNoeloNT3s-q1gxExHw1hxWXxXjzwQ_0rmYTHzyTjcLU-Ug16hprVBqPJCcaqUdpPKwmaPqq7vZ1PMKvCzUzo5zpMKD82crwESBWiElrO6a5sruuLXTbB7fBuNifv_anSuD6Bl3wgx-_HS-1g-52H4NxZuXKnwCVrVyp63yQy1dpR9hkcQ_ttvyz3zcSch_dkvkDdKcpM7p-iN5dlhO7yGwjJ_YgJ3YnJ_ZETh6h408fF4dzpy2a4TDAGZUTAACmhEYCDEcc04wGYcQjyj03BXRIMeckdgMBMJVRngohwIPmKca-ZDqVv8SP0XZe5PIpsj2PcKJTPMoUB4ylNPKyzM88sApCX2-00CtNqKT9I8rEOJR-nABhE0PYxA8s9KYjY3LWJFC5Ydw-0DgRSrceuPEAlDxCwD1wwWTEsYVedtRPQAPqYy2Wy6IuE7BSIY60LbHQk4Yb_UodTy0UT_jUD9DZ1ac9uTo1WdZ1bF0YYLJ346TP0M7wTzxH29V5LfcBolb8hZG7PyCUkBo |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+of+human+tibrovirus+envelope+glycoproteins&rft.jtitle=Journal+of+virology&rft.au=Munyeku-Bazitama%2C+Yannick&rft.au=Saito%2C+Takeshi&rft.au=Hattori%2C+Takanari&rft.au=Miyamoto%2C+Hiroko&rft.date=2024-07-23&rft.eissn=1098-5514&rft.volume=98&rft.issue=7&rft.spage=e0049924&rft_id=info:doi/10.1128%2Fjvi.00499-24&rft_id=info%3Apmid%2F38953631&rft.externalDocID=38953631 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |